GSK Investigational Site

Jiujiang, Jiangxi 332000

0 studies enrolling now · 1 studies all time

What they study most

Arthritis, Rheumatoid

Studies at this site

• Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic (cs)/Biologic (b) Disease Modifying Anti-rheumatic Drugs (DMARDs) — Stopped early